President Trump Announces New Drug Pricing Plan
On October 25, President Trump released a new drug pricing plan. With the goal of reducing the cost of prescription drugs, this proposal focuses on Medicare drugs administered in physician offices and hospital outpatient clinics. Medicare Part D remains unchanged at this point. The announcement lays out a pilot program that focuses on three areas:
- Creates a new pricing index for Medicare Part B drugs through a pilot program covering up to 50% of the country.
- Allows drugs to be sold to vendors instead of directly to medical professionals and hospitals.
- Changes the current fee structure for storing medications from a percentage fee to a flat fee.
It is important to note that this is an advance notification for future rulemaking. We expect a formal proposal to come out in Spring 2019 with implementation in Fall 2019. Please keep an eye on the Emory Capitol Report for updates. For more information, please see the fact sheet here: https://www.cms.gov/newsroom/fact-sheets/anprm-international-pricing-index-model-medicare-part-b-drug
Emory featured in NAUBO advocacy materials
The National Association of College and University Business Officers (NACUBO) has recognized Emory’s federal team for its collaborative advocacy work. In a recent release, NACUBO highlights the important work being led by Emory’s Director of Federal Affairs, Jessica Davis. The NACUBO interview with Jessica, as well as her advocacy tips, can be found here. |